What could sound more revolutionary than a “cancer moonshot?” Or, the recent “groundbreaking” message heard around the world of a company claiming a
biotech
A company made grand pronouncements about revolutionizing cancer treatment claiming their discovery is so disruptive that, according to its
Medicare and Medicaid cannot negotiate the cost of drugs – meaning they have to pay whatever a pharmaceutical company charges for their drugs.
The New York Times editorial board apparently has dec
Scientists working at Rothamsted Research, a publicly-financed center in the U.K., began an agricultu
A recent graduate of the Grocery Manufacturers Association, Sean McBride, has established his own consultancy and
Over the course of the last two decades, genetically-engineered (biotech, GMO) agricultural products (
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
